Lower virus neutralizing titers against SARS-CoV-2 Omicron strain after third dose BNT162b2 following primo-vaccination with ChAdOx1 versus BNT162b2 in cancer patients
Annals of Oncology ; 33:S1305-S1305, 2022.
Article in English | Academic Search Complete | ID: covidwho-2027894
Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients.
ESMO Open ; 7(2): 100414, 2022 04.
Article in English | MEDLINE | ID: covidwho-1670486
Subject(s)COVID-19 , Neoplasms , BNT162 Vaccine , COVID-19/prevention & control , COVID-19 Vaccines , Humans , Vaccination
Annals of Oncology ; 32:S1387-S1388, 2021.
Article in English | Web of Science | ID: covidwho-1588324